ZVSA insider filings

ZyVersa Therapeutics, Inc. — 26 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-07-16. Screen ZVSA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ZVSA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ZyVersa Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2025-07-164Cashmere Karen A. — Chief Commercial OfficerGrant/award (A): 48,100 (derivative) @ $0EDGAR
2025-07-154Wolfe Peter — Chief Financial OfficerGrant/award (A): 60,100 (derivative) @ $0EDGAR
2025-07-154Park Min-Chul — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Guzman Pablo A. — Chief Medical OfficerGrant/award (A): 48,900 (derivative) @ $0EDGAR
2025-07-154SAPIRSTEIN JAMES — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Finizio Robert G — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Freitag Gregory Gene — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Glover Stephen C. — Chief Executive Officer, DirectorGrant/award (A): 136,900 (derivative) @ $0EDGAR
2024-07-184Wolfe Peter — Chief Financial OfficerGrant/award (A): 715 (derivative) @ $0EDGAR
2024-07-184Park Min-Chul — DirectorGrant/award (A): 132 (derivative) @ $0EDGAR
2024-07-184Cashmere Karen A. — DirectorGrant/award (A): 572 (derivative) @ $0EDGAR
2024-07-184SAPIRSTEIN JAMES — DirectorGrant/award (A): 132 (derivative) @ $0EDGAR
2024-07-184Finizio Robert G — DirectorGrant/award (A): 132 (derivative) @ $0EDGAR
2024-07-184Freitag Gregory Gene — DirectorGrant/award (A): 132 (derivative) @ $0EDGAR
2024-07-184Glover Stephen C. — Chief Executive Officer, DirectorGrant/award (A): 1,627 (derivative) @ $0EDGAR
2023-08-034INCON Co., Ltd. — 10% ownerHoldings only — no transactions reportedEDGAR
2023-01-264Guzman Pablo A. — Chief Medical OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-12-204Wolfe Peter — Chief Financial OfficerGrant/award (A): 3,000 @ $2.88EDGAR
2022-12-164INCON Co., Ltd. — 10% ownerGrant/award (A): 1,497,199 @ $0 · Grant/award (A): 450,702 (derivative) @ $0EDGAR
2022-12-144Wolfe Peter — Chief Financial OfficerGrant/award (A): 41,585 · Grant/award (A): 9,927 (derivative) @ $0 · Grant/award (A): 9,927 (derivative) @ $0 · Grant/award (A): 39,708 (derivative) @ $0 · Grant/award (A): 21,840 (derivative) @ $0 · Grant/award (A): 21,840 (derivative) @ $0 · +2 moreEDGAR
2022-12-144Park Min-Chul — DirectorGrant/award (A): 29,781 (derivative) @ $0 · Grant/award (A): 9,927 (derivative) @ $0EDGAR
2022-12-144Cashmere Karen A. — Chief Commercial OfficerGrant/award (A): 9,927 (derivative) @ $0 · Grant/award (A): 19,854 (derivative) @ $0 · Grant/award (A): 29,781 (derivative) @ $0 · Grant/award (A): 21,840 (derivative) @ $0 · Grant/award (A): 21,840 (derivative) @ $0EDGAR
2022-12-144Finizio Robert G — DirectorGrant/award (A): 29,781 (derivative) @ $0 · Grant/award (A): 19,854 (derivative) @ $0 · Grant/award (A): 9,927 (derivative) @ $0EDGAR
2022-12-144LaBella Nicholas A. Jr. — Chief Scientific OfficerGrant/award (A): 18,094 · Grant/award (A): 19,854 (derivative) @ $0 · Grant/award (A): 39,709 (derivative) @ $0 · Grant/award (A): 59,563 (derivative) @ $0 · Grant/award (A): 39,708 (derivative) @ $0 · Grant/award (A): 29,781 (derivative) @ $0 · +2 moreEDGAR
2022-12-144O'Connor Daniel J. — Director, 10% owner
Larkspur Health LLC — 10% owner
Other (J): 1,377,598 @ $0 · Other (J): 1,750 (derivative) · Other (J): 1,750 (derivative) · Other (J): 177,204 (derivative) @ $0EDGAR
2022-12-144Glover Stephen C. — Chief Executive Officer, DirectorGrant/award (A): 448,909 · Grant/award (A): 85,442 · Grant/award (A): 49,636 · Grant/award (A): 43,847 · Grant/award (A): 18 (derivative) · Grant/award (A): 138,980 (derivative) @ $0 · +8 moreEDGAR

Recent 8-K events — ZyVersa Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-07-168-K8.01 — Other EventsEDGAR
2026-07-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2026-03-058-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-09-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-07-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-168-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-098-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ZVSA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs